Publications by authors named "M Dolores Ruiz Carmona"

Background And Objective: Staging Parkinson's disease (PD) with a novel simple classification called MNCD, based on four axes (Motor; Non-motor; Cognition; Dependency) and five stages, correlated with disease severity, patients' quality of life and caregivers' strain and burden. Our aim was to apply the MNCD classification in advanced PD patients treated with device-aided therapy (DAT).

Patients And Methods: A multicenter observational retrospective study of the first patients to start the levodopa-entacapone-carbidopa intestinal gel (LECIG) in Spain was performed (LECIPARK study).

View Article and Find Full Text PDF
Article Synopsis
  • The oil and gas industry is grappling with climate change and resource depletion, prompting a shift towards enhanced recovery methods like polymer flooding, which boasts higher recovery rates and lower emissions.
  • Existing physical models for predicting polymer flooding outcomes need improvement, particularly in accurately modeling the flow behavior of polymer solutions.
  • The new PAMA-T model expands the original PAMA technique to make it applicable across a wider temperature range (298-343 K), enabling better predictions of rheological properties using minimal data input from viscosity measurements.
View Article and Find Full Text PDF

Background: Hospitalization for Transurethral Prostate Resection (TURP) involves circadian rhythm disturbance - a possible cause of Postoperative Neurocognitive Disorder (POCD) in elderly patients. This study investigated whether melatonin ameliorated this effect.

Methods: A double-blind, randomized clinical trial used a battery of neuropsychological tests to evaluate cognitive performance of 118 patients aged ≥ 60, before TURP with spinal anesthesia, and at 21- and 180-days PO.

View Article and Find Full Text PDF

Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second most common cause of cancer-related death in both men and women. Although a number of treatments are available to combat this malignancy, the antimetabolite 5-fluorouracil has been the cornerstone of therapy since its synthesis in the 1950s. Unfortunately, the prolonged use of 5-fluorouracil can lead to chemoresistance, which has prompted research into combination regimens to improve efficacy and quality of life and reduce resistance.

View Article and Find Full Text PDF